Premium
Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention
Author(s) -
Dietze Paul,
Cantwell Kate
Publication year - 2016
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/add.13260
Subject(s) - opioid overdose , (+) naloxone , opioid , medicine , opioid epidemic , opioid related disorders , nasal administration , drug overdose , opioid abuse , opioid addiction , anesthesia , poison control , medical emergency , intensive care medicine , psychiatry , pharmacology , receptor
Commentary to: Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom